Medicine and Dentistry
Patient
100%
At Risk Mental State
56%
Client
56%
Early Intervention
56%
Prodromal Symptom
56%
Drug Use
56%
Electronic Health Record
56%
Frailty
56%
Cohort Analysis
56%
Association
56%
Fracture
56%
Rivaroxaban
56%
Apoplexy
56%
Warfarin
46%
Primary Health Care
37%
Antipsychotics
37%
Drug Megadose
37%
Early Intervention in Psychosis
28%
Age
24%
Therapeutic Procedure
24%
Person
24%
High Risk Population
18%
Physician
18%
Patient Referral
18%
Mental Health Service
18%
Disease
18%
Transient Ischemic Attack
18%
Direct Oral Anticoagulant
18%
Symptom
18%
Follow up
15%
Dementia
12%
Femur Fracture
12%
Diagnosis
12%
Brain Injury
9%
Randomized Controlled Trial
9%
Antiphospholipid Antibody
9%
Disease Marker
9%
Adult
9%
Secondary Prevention
9%
Magnetic Resonance Imaging
9%
Antithrombotic Therapy
9%
Drug Exposure
6%
Incidence
6%
Drug Therapy
6%
Woman
6%
Psychology
Mental State
56%
Ethnic Minority
56%
Systematic Review
56%
Quality
56%
Mental Health Service
28%
Demographics
28%
Overrepresentation
28%
Methodology
14%
Study Design
14%
Inclusion
14%
Attention
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
65%
Risperidone
56%
Cluster Randomized Trial
56%
Cohort Study
56%
Schizophrenia
56%
Study Design
28%
Atypical Antipsychotics
9%
Pharmacokinetic Modeling
9%
Pharmacotherapy
5%
